A baby born with a rare disorder has been treated with a personalized genetic treatment, with reports indicating the treatment is showing promise. The use of CRISPR gene editing in this case appears to be a world's first for a baby with a genetic disease. The treatment's success has sparked interest in the potential for individualized medicines, with the FDA expressing interest in facilitating such therapies.